Pre-transplant depression as risk factor for survival of patients undergoing allogeneic haematopoietic stem cell transplantation

被引:49
作者
Grulke, Norbert [1 ]
Larbig, Wolfgang [2 ]
Kaechele, Horst [1 ]
Bailer, Harald [1 ]
机构
[1] Univ Ulm, Univ Klin Psychosomat Med & Psychotherapie, D-89075 Ulm, Germany
[2] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany
关键词
cancer; oncology; haematopoietic stem cell transplantation; depression; survival;
D O I
10.1002/pon.1261
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Depression is discussed as a possible risk factor for survival in cancer patients. We explored this relationship for patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT). Patients and methods: The depression subscale of the Hospital Anxiety and Depression Scale (HADS) served as a measure for depression. One hundred and thirty-eight patients (mean age 41 years; different diagnoses) participating in a psycho-oncology study filled in the HADS after admission for allogeneic HSCT. They were followed-up for at least two years; 72 patients died during follow-up. Results: Depression scores were not correlated with medical and psychosocial objective factors with the exception of having under-aged children. Controlling for medical factors that showed up as predictors for survival in our sample (patient's age at HSCT, having had a transplant before, risk for treatment failure) the HADS depression score (range 0-21) emerged as an independent predictor (Cox regression): hazard ratio = 1.087; 95% Cl = 1.018-1.161. Conclusion: Depression is probably not a simple indicator of a worse health status. Further research is needed to decide if depression must be considered as an independent risk factor for survival when diagnosed in the pre-transplant period. Copyright (C) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:480 / 487
页数:8
相关论文
共 28 条
[1]   Psychological factors and survival after bone marrow transplantation in patients with leukemia [J].
Akaho, R ;
Sasaki, T ;
Mori, SI ;
Akiyama, H ;
Yoshino, M ;
Hagiya, K ;
Nakagome, K ;
Sakamaki, H .
PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2003, 57 (01) :91-96
[2]   Depression and survival after hematopoietic stem cell transplantation: Where do we go from here? [J].
Andrykowski, MA .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) :5878-5880
[3]  
BAILER H, VERHALTENST IN PRESS
[4]  
BJELLAND I, 2002, J PSYCHOSOM RES, V0052
[5]  
Bottomley A, 1998, Eur J Cancer Care (Engl), V7, P181
[6]   Prognostic index for adult patients with acute myeloid leukemia in first relapse [J].
Breems, DA ;
Van Putten, WLJ ;
Huijgens, PC ;
Ossenkoppele, GJ ;
Verhoef, GEG ;
Verdonck, LF ;
Vellenga, E ;
De Greef, G ;
Jacky, E ;
Van der Lelie, J ;
Boogaerts, MA ;
Löwenberg, B .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (09) :1969-1978
[7]  
Cohen J., 1988, POWERSTATISTICALSCIE, DOI 10.4324/9780203771587
[8]  
FALLER H, 2004, Z MED PSYCHOL, V13, P99
[9]   Allogeneic BMT and patient eligibility based on psychosocial criteria: a survey of BMT professionals [J].
Foster, LW ;
McLellan, LJ ;
Rybicki, LA ;
Dabney, J ;
Welsh, E ;
Bolwell, BJ .
BONE MARROW TRANSPLANTATION, 2006, 37 (02) :223-228
[10]   Is perceived social support a predictor of survival for patients undergoing autologous peripheral blood stem cell transplantation? [J].
Frick, E ;
Motzke, C ;
Fischer, N ;
Busch, R ;
Bumeder, I .
PSYCHO-ONCOLOGY, 2005, 14 (09) :759-770